Send the following on WhatsApp
Continue to Chat積極攻下慢性發炎疾病領域,首個生物製劑藥品 Kevzara 核准用於風濕性多肌痛症(PMR)! https://geneonline.news/pmr-regeneron-sanofi-kevzara-approval/
積極攻下慢性發炎疾病領域,首個生物製劑藥品 Kevzara 核准用於風濕性多肌痛症(PMR)! https://geneonline.news/pmr-regeneron-sanofi-kevzara-approval/